Zhi L. Teo

305 Grattan St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.

Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancer.

Journal: Journal of the National Cancer Institute

Published: August 10, 2022

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Journal: Breast cancer research : BCR

Published: July 15, 2022

Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.

Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.

Journal: Cancer cell

Published: May 04, 2022

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

Journal: NPJ breast cancer

Published: October 27, 2021

Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Journal: Breast cancer research : BCR

Published: May 11, 2020

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 16, 2019

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.

Publisher Correction: Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.

Journal: Nature medicine

Published: August 24, 2018

Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.

Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.

Journal: Nature medicine

Published: November 28, 2017

Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer.

Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer.

Journal: Cancer research

Published: August 01, 2017

Advancing Immunotherapy in Metastatic Breast Cancer.

Advancing Immunotherapy in Metastatic Breast Cancer.

Journal: Current treatment options in oncology

Published: May 24, 2017

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".

Journal: PLoS medicine

Published: April 22, 2017

Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?

Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?

Journal: BMC cancer

Published: November 13, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026